Medication info

Jungwoo 10% Glucose Injection

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›100g / 1000mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
A colorless, transparent liquid contained in a polypropylene, multilayer film plastic container or glass container.
Packaging
500mL/bag, 1000mL/bag
Approval status
Active

MFDS item code 196800017 · Notified 1968.11.04 · Insurance code 644901872,644901881

Summary

Main use
Provides fluids and energy (such as for hypoglycemia), treats heart disease, and treats drug and toxic substance poisoning
Who receives it
Adults
Adult administration
Adults: Administer 20~500 mL per dose by intravenous injection. The intravenous drip infusion rate should be no more than 0.5 g/kg per hour, calculated as glucose. Use an appropriate amount to dissolve or dilute injectable drugs. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Provides fluids and energy (such as for hypoglycemia), treats heart disease, and treats drug and toxic substance poisoning

  • Hyperkalemia
  • circulatory collapse
  • hypoglycemia
View approved original text

This medication helps supply energy during conditions such as hyperkalemia, circulatory collapse, and hypoglycemia. It is also used to provide fluids and energy during treatment for heart diseases. It is used to support recovery in cases of drug or toxin overdose. Additionally, it is effective for overall fluid and energy replenishment, making it helpful in various situations. Therefore, this medicine is used for treating hyperkalemia, circulatory collapse, hypoglycemia, heart disease, and toxin overdose.

How it is given

Adult administration

Adults: Administer 20~500 mL per dose by intravenous injection. The intravenous drip infusion rate should be no more than 0.5 g/kg per hour, calculated as glucose. Use an appropriate amount to dissolve or dilute injectable drugs. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication may allow glass fragments to enter when using the ampoule, so extreme caution is necessary when breaking the ampoule, especially for administration to children and the elderly. This medication containing dextrose can increase the depletion of vitamin B1 (thiamine) during intravenous injection, potentially causing severe deficiencies. This drug should not be administered to patients with specific conditions, including storage dehydration, excess fluid status, hyperglycemia, acidosis, hypokalemia, hyperosmolar coma, diabetes insipidus, anuria, hepatic coma, and others. Moreover, the hypertonic formulation of this drug should not be used in patients with spinal canal hemorrhage or intracranial bleeding, and those with tremor-related delirium. Caution is advised when administering to patients with tendencies for potassium, phosphate, magnesium deficiencies, hyponatremia, diabetes insipidus, renal failure, heart failure, severe malnutrition, thiamine deficiency, sepsis, or severe trauma. Massive or rapid administration of this drug may cause electrolyte imbalances and fluid overload. Exceeding the recommended dose may lead to elevated bilirubin and lactate levels in the blood. During intravenous administration, attention should be paid to potential side effects such as fluid and electrolyte imbalances, congestion, and pulmonary edema. Diabetic patients or those with glucose intolerance may experience hyperglycemia and renal loss. Long-term administration could affect insulin secretion, therefore insulin therapy should be considered if necessary. For patients post-surgery or post-trauma, it is safer to administer as a 5% solution under blood sugar control for those with glucose intolerance. Serum electrolyte tests and thorough monitoring of fluid balance and blood sugar levels must be maintained, alongside careful observation of the patient’s condition and various blood test values. During pregnancy, safety for the fetus has not been established, and this drug should only be given when the therapeutic benefits outweigh the risks. When administered during labor, both mother and newborn may experience metabolic abnormalities such as hyperglycemia or hypoglycemia, so careful judgment is required. In neonates, especially premature or low-birth-weight infants, the risk of hypoglycemia and hyperglycemia is high, thus blood sugar should be closely monitored. Elderly patients should be administered with extra caution due to decreased physiological function. In case of overdose resulting in hyperglycemia or diabetes symptoms, insulin administration is required for control. Subcutaneous injections should be avoided due to the risk of local irritation and circulatory failure; any remaining drug should be discarded immediately after opening. To reduce the risk of infection during injection, maintain hygiene, and it is advisable to warm the drug to body temperature before administration. Sudden discontinuation after administering high-concentration solutions may induce hypoglycemia, hence caution is needed. When mixed with other medications, there may be chemical or physical side effects, thus thorough understanding and observation are necessary. Additionally, it is preferable to avoid continuous connections to reduce the risk of air embolism within the container.

Side effects

  • Electrolyte loss
  • elevated bilirubin levels
  • elevated lactate levels
  • hypokalemia
  • hyperosmolar coma
  • acidosis
  • dehydration
  • hyperosmolality
  • polyuria
  • fluid or solute overload
Show 11 more
  • fluid electrolyte imbalance
  • congestion
  • pulmonary edema
  • hyperglycemia
  • renal loss
  • fever
  • phlebitis
  • thrombosis
  • hemorrhage
  • pain at the injection site
  • uremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that prevents air or moisture intrusion. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A colorless, transparent liquid contained in a polypropylene, multilayer film plastic container or glass container.

Package unit

500mL/bag, 1000mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.